ArticleCurrent pharmaceutical design2025
Crippled Hepatocarcinogenesis Inhibition of Quercetin in Glycolysis Pathway with Hepatic Farnesoid X Receptor Deficiency.
Wusheng Zhong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it